The global nanopharmaceutical drugs market is projected to be worth USD 82.71 Billion by 2027, according to a current analysis by Emergen Research. The advantages offered by nanopharmaceutical drugs comprise targeting lesions/tumor cells, apoptosis commencement, and drug accumulation in specific tissue for improved cancer cells’ exposure cells. Existing pharmaceuticals...